Signaling Pathways - PD-1/PD-L1 interaction - Sulfonylurea receptors - Ca2 /calmodulin-dependent protein kinases (CaMKs) - FLT3
清除全部
-
B6023 PD-1/PD-L1 inhibitor 2Target: PD-1/PD-L1 interactionSummary: PD-1/PD-L1相互作用的抑制剂 -
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI) -
B5854 Pexidartinib (PLX3397)3 Citation中文名: 培西达替尼Target: FLT3|c-Kit|CSF1RSummary: CSF-1R抑制剂 -
B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: VEGFR-2\PDGFRβ\Flt-3和c-Kit的抑制剂 -
B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂 -
B4969 KN-93 PhosphateTarget: Ca2 /calmodulin-dependent protein kinases (CaMKs)Summary: CaM激酶II抑制剂 -
B8016 UNC20251 CitationTarget: MER|FLT3Summary: 口服生物可利用的双重MER/FLT3抑制剂 -
A8889 G-749Target: Aurora Kinases|FLT3|c-RETSummary: FLT3抑制剂 -
B6803 Rottlerin1 Citation中文名: 揪毒素Target: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2Summary: PKC抑制剂 -
B6831 Autocamtide-2-related inhibitory peptideTarget: Ca2 /calmodulin-dependent protein kinases (CaMKs)Summary: 钙调蛋白依赖性蛋白激酶II（CaM激酶II，CaMKII）抑制剂